Molecular Medicine Tri-Conference wiill be held in San Francisco and attract several thousand people from several dozen nations to learn about molecular medicine from the angles of diagnostics, genomics, cancer and informatics

When asked, SILEX Pharmacetical’s Anthony Mack notes that—like most pain killers—cannabis works for some, but not everyone.“Pain,” he notes, “is pretty subjective.” To render it less so is the mission of SILEX

Valneva to supply process development services for EB66-based influenza vaccines–Advanced Development program sponsored by the U.S. Department of Health and Human Services—Valneva to receive research fees under the new agreement

U.S. study sites enrolling adult patients with genetically defined solid tumors, including malignant rhabdoid tumors, in registration-supporting Phase 2 study Also, U.S. study sites enrolling pediatric patients with genetically defined solid tumors, including malignant rhabdoid tumors, in Phase 1 dose escalation study

CytoDyn reports HIV patients approaching 17 months of complete viral suppression with PRO 140 monotherapy

A 'gap in the armor' of DNA may allow enzyme to trigger cancer-causing mutations, IU study finds

Liquid biopsy test delivers high negative predictive value of 99.2 percent for Bladder Cancer

The technology for viewing, sharing, analysis and management of large sets of images and metadata will enable new collaborations and research

Idera Pharmaceuticals reports positive data from ongoing Phase 1/2 clinical trial of toll-like receptor in patients with Waldenström’s macroglobulinemia

Industry leaders are adopting ‘best of breed’ applications in eClinical stack to speed clinical trials

Study reached 120 qualifying events; top-line results expected in Q2 2016

Nanoemulsion adjuvanted vaccines demonstrate positive preclinical results in genital herpes, HIV and chlamydia